Genetics
Neurogenetic Disorders Tests in Dubai & UAE
Investigations in this area, with the specimen type, turnaround time and listed price for each option — so you and your clinician can compare before you book.
- Quality-controlled laboratory
- Home collection across the UAE
- Confidential handling of results
Compare options
Neurogenetic Disorders investigations
All 25 investigations in this category are listed below.
| Test | What it measures | Specimen | Turnaround | Price | Book |
|---|---|---|---|---|---|
| AIFM1 Gene (CMTX4) Genetic Test TEST-4115 LOINC 94893-5 | This genetic test identifies pathogenic variants in the AIFM1 gene associated with X-linked Charcot-Marie-Tooth disease type 4 (CMTX4). | Peripheral whole blood | 3 – 4 weeks | 2,800.00 AED | Details |
| ARX Gene Lissencephaly (X-linked Type 2) NGS Test TEST-2637 LOINC 94243-9 | This test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly type 2 and related brain malformations. | Peripheral Whole Blood or Dried Blood Spot (FTA Card) | 3 to 4 Weeks | 2,800.00 AED | Details |
| ATP1A2 Gene Familial Hemiplegic Migraine Type 2 Genetic Test TEST-4406 LOINC 48000-6 | This genetic test identifies pathogenic variants in the ATP1A2 gene associated with Familial Hemiplegic Migraine Type 2. | Peripheral whole blood (3–5 mL in EDTA tube) or FTA card | 3–4 weeks (from sample receipt at laboratory) | 2,800.00 AED | Details |
| ATXN2 Gene Spinocerebellar Ataxia Type 2, Autosomal Dominant Genetic Test TEST-5872 LOINC 38153-2 | This test identifies pathogenic CAG trinucleotide repeat expansions in the ATXN2 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 2 (SCA2). | Whole Blood (Peripheral) | 3 to 4 Weeks | 2,800.00 AED | Details |
| ATXN3 Gene Spinocerebellar Ataxia Type 3 (SCA3) Genetic Test TEST-5885 LOINC 47528-5 | This diagnostic test evaluates the ATXN3 gene for CAG trinucleotide repeat expansions, which are the cause of Spinocerebellar Ataxia Type 3 (SCA3). It... | Peripheral Whole Blood | 3 to 4 weeks | 2,800.00 AED | Details |
| BPIFA3 Gene Genetic Test for Autism Spectrum Disorder (ASD) TEST-3849 LOINC 81317-3 | This test identifies pathogenic and likely pathogenic variants in the BPIFA3 gene associated with Autism Spectrum Disorder (ASD) susceptibility. | Peripheral Whole Blood | 3 – 4 weeks | 2,800.00 AED | Details |
| CDH15 Gene Mental Retardation, Autosomal Dominant Type 3 (MRD3) Genetic Test TEST-4833 LOINC 104200-5 | This genetic test evaluates the CDH15 gene for pathogenic variants associated with autosomal dominant intellectual disability type 3 (MRD3). It utiliz... | Peripheral Whole Blood (preferred) or DNA on FTA Card | 3 – 4 weeks | 2,800.00 AED | Details |
| CLCN4 Gene Raynaud‑Claes Syndrome Genetic Test TEST-5644 LOINC 21636-6 | This genetic test analyzes the CLCN4 gene for mutations associated with Raynaud‑Claes syndrome. | Peripheral Whole Blood, DNA Extract, or FTA Card | 3 – 4 Weeks | 2,800.00 AED | Details |
| CTNNB1 Gene Intellectual Disability (Autosomal Dominant 19) Genetic Test TEST-4818 LOINC 21613-4 | This test identifies pathogenic variants in the CTNNB1 gene associated with autosomal dominant intellectual disability type 19. | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| FOXP1 Gene Sequencing for Intellectual Disability with Language Impairment & Autistic Features (Genetic Test) TEST-4890 LOINC 101955-1 | This test identifies pathogenic variants within the FOXP1 gene, which are associated with specific neurodevelopmental disorders. | Whole Blood (EDTA) or FTA Card; Extracted DNA accepted upon quality review | 3 to 4 Weeks | 2,800.00 AED | Details |
| GLRB Gene Hyperekplexia Genetic Test TEST-4615 LOINC 94480-2 | This genetic test analyzes the GLRB gene for variants associated with hereditary hyperekplexia. | Peripheral whole blood (3-5 mL EDTA), extracted DNA (1 µg), or dried blood spot on FTA card | 3 – 4 Weeks | 2,800.00 AED | Details |
| ITPR1 Gene Spinocerebellar Ataxia Type 15 Genetic Test TEST-5757 LOINC 94077-1 | This test identifies pathogenic variants within the ITPR1 gene associated with Spinocerebellar Ataxia Type 15 (SCA15). | Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) | 21 calendar days | 2,800.00 AED | Details |
| JPH3 Gene Huntington Disease‑Like 2 (HDL2) Genetic Test TEST-4602 LOINC 101452-2 | This test detects CTG repeat expansions in the JPH3 gene, confirming Huntington disease-like 2 (HDL2). | Whole Blood (EDTA) or FTA Card | 3–4 weeks | 2,800.00 AED | Details |
| LMNA Gene CMT2B1 Genetic Test TEST-4068 LOINC 94849-5 | This genetic test analyzes the LMNA gene to detect mutations associated with Charcot-Marie-Tooth disease type 2B1, a hereditary neuropathy. | Peripheral Whole Blood (EDTA) or FTA Card (Dried Blood Spots) | 3 – 4 Weeks | 2,800.00 AED | Details |
| LMNB1 Gene (Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy) Genetic Test TEST-4756 LOINC 21636-7 | This genetic test detects duplications in the LMNB1 gene, which are the cause of autosomal dominant adult-onset demyelinating leukodystrophy (ADLD). | Peripheral whole blood (2 × EDTA tubes, 4–6 mL total), extracted genomic DNA, or FTA card | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| LRPPRC Gene Sequencing (Leigh Syndrome, French-Canadian Type) Test TEST-4668 LOINC 81247-9 | This test evaluates the LRPPRC gene for pathogenic variants associated with Leigh syndrome, French-Canadian type. | Whole blood (EDTA), extracted DNA, or FTA card | 3–4 Weeks | 2,800.00 AED | Details |
| NDUFAF2 Gene Leigh Syndrome Genetic Test TEST-4631 LOINC 95213-9 | This test evaluates the NDUFAF2 gene for pathogenic variants associated with Leigh syndrome. | Blood (EDTA) or FTA Card | 3 – 4 Weeks | 2,800.00 AED | Details |
| SLC2A1 Gene (DYT18) Genetic Test TEST-4250 LOINC 21633-4 | This test identifies pathogenic variants in the SLC2A1 gene associated with GLUT1 deficiency syndrome. | Peripheral Whole Blood (EDTA tube) | 3–4 Weeks | 2,800.00 AED | Details |
| Spinocerebellar Ataxia Type 7 (SCA7) ATXN7 Gene Mutation Test TEST-3105 LOINC 78000-9 | This test detects pathogenic CAG trinucleotide repeat expansions in the ATXN7 gene, confirming a diagnosis of Spinocerebellar Ataxia Type 7. | Whole blood | 5 working days (Sample by Tuesday 11 am → Report Saturday) | 750.00 AED | Details |
| TDP1 Gene (SCAN1) Spinocerebellar Ataxia with Axonal Neuropathy Genetic Test TEST-5906 LOINC 77785-2 | This genetic test evaluates the TDP1 gene for pathogenic variants associated with Spinocerebellar Ataxia with Axonal Neuropathy (SCAN1). | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| TIMM8A Gene Opticoacoustic Nerve Atrophy with Dementia Genetic Test TEST-5543 LOINC 81323-0 | This test analyzes the TIMM8A gene for mutations associated with Mohr-Tranebjaerg syndrome. | Peripheral Blood or Buccal Swab | 3 to 4 weeks | 2,800.00 AED | Details |
| TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test TEST-5899 LOINC 81247-9 | This test evaluates the TPP1 gene for pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 7 (SCAR7). | Peripheral Whole Blood or Buccal Swab | 3–4 weeks | 2,800.00 AED | Details |
| VPS53 Gene Pontocerebellar Hypoplasia Type 2E Genetic Test TEST-5503 LOINC 98936-4 | This genetic test analyzes the VPS53 gene to detect pathogenic variants associated with Pontocerebellar Hypoplasia Type 2E (PCH2E). | Peripheral Whole Blood | 3-4 Weeks | 2,800.00 AED | Details |
| WNK1 Gene HSAN2A Genetic Test TEST-4582 LOINC 55989-0 | This genetic test detects pathogenic variants in the WNK1 gene associated with hereditary sensory and autonomic neuropathy type IIA (HSAN2A). | Whole blood (EDTA), extracted DNA, or FTA card (blood spot) | 3–4 weeks | 2,800.00 AED | Details |
| ZNF41 Gene Mental Retardation, X-linked Type 89 Genetic Test TEST-4944 LOINC 55233-1 | This test analyzes the ZNF41 gene to identify pathogenic variants associated with X-linked intellectual disability type 89. | Peripheral Whole Blood (3-5 mL EDTA tube) or FTA Card Dried Blood Spot | 3–4 Weeks | 2,800.00 AED | Details |
Clinical overview
About Neurogenetic Disorders
Before your appointment
Preparation & sample collection
Follow the instructions you are given
Fasting, timing and medicine restrictions differ between investigations. The instructions for your specific request are confirmed when you book.
Bring your identification
A valid photo ID is required at collection so that your sample is matched correctly to your record.
Tell us about medicines
Prescription medicines, supplements and recent procedures can affect how an investigation is scheduled or interpreted — please mention them.
Ask before collection
If anything about preparation is unclear, contact us before your appointment. Preparation errors can affect reporting times.
Patient information
Frequently asked questions
Practical answers about Neurogenetic Disorders testing at DNA Labs UAE. This information is general and does not replace advice from your treating clinician.
How do I choose the right Neurogenetic Disorders test?
The correct investigation depends on what your clinician is trying to establish. Review the specimen type and turnaround time below, then confirm the choice with your treating doctor before booking.
What specimen is required?
Specimen requirements are listed for each investigation. If a request involves more than one sample type, our team will confirm what is needed at the time of booking.
Do you offer home sample collection in Dubai and the UAE?
Yes. Home collection can be arranged across Dubai and the wider UAE. Availability and appointment windows vary by location, so please confirm when you book.
How long do results take?
Turnaround depends on the investigation and the method used. The expected reporting time is confirmed with you before collection.
Is there anything I need to do before sample collection?
Some investigations require fasting, a specific collection time, or avoiding certain medicines or activities. Preparation details are shared when you book — please follow them and ask if anything is unclear.
How will I receive my report?
Reports are issued as secure digital documents and can be shared with your referring clinician on request. Please review results with a qualified clinician who can interpret them in context.
About this clinical information
The information on this Neurogenetic Disorders page describes laboratory investigations in general terms. It is written to help you understand what an investigation involves — it is not a diagnosis and it is not a substitute for advice from your treating clinician.
- Investigation names, specimen types and listed prices are reviewed against laboratory records.
- Preparation guidance is indicative — confirm test-specific instructions before collection.
- Content is updated when investigations, methods or reporting formats change.
- Results are released to the patient and, on request, shared with the referring clinician.
Medical disclaimer: This page is for general information and education only. It is not medical advice, diagnosis or treatment, and it does not replace a consultation with a qualified healthcare professional. Always seek the advice of your doctor or another qualified provider with any questions about a medical condition or before ordering a test.
We're here to help
Need help choosing a Neurogenetic Disorders test?
Tell us what your clinician has requested and we'll confirm availability, price, preparation and the most convenient collection option — including home collection in Dubai and across the UAE.
- Home collection available across the UAE
- Digital reports delivered securely
- Confidential handling of every request
Related areas